Agilysys, Inc. (AGYS) Plans CEO Search; CFO Seebeck Resigns
- Wall Street dips on Trump protectionism, Qualcomm drag
- Yahoo! (YHOO) Tops Q4 EPS by 4c; Sees Verizon Deal Closing in Q2, Not Q1
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- After-Hours Stock Movers 1/23: (REXX) (MRCY) (SYNC) Higher; (FSM) (OCUL) (CASC) Lower (more...)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Agilysys, Inc. (Nasdaq: AGYS) announced that it has initiated a search process to identify a successor CEO to lead the next stage of the Company's growth.
Michael Kaufman, Chairman of the Agilysys Board of Directors, stated, "Under Jim's leadership, Agilysys narrowed its focus to directly address the needs of hospitality operators with leading solutions that enable our customers to create closer connections with their guests. As a result, the Company has returned to consistent double digit revenue growth, developed and introduced the rGuest platform, the industry’s first advanced technology platform for lodging and food and beverage hospitality operations, and delivered a suite of cloud-based solutions that will transform the guest experience.
“Looking forward, the opportunities available to Agilysys have expanded dramatically in the past year, and the Board is committed to accelerating spend on go-to-market strategy and actions that support our objectives. We have already established a search committee that is working diligently to identify a proven, high performance executive to take advantage of the significant growth opportunities in front of us while further positioning the Company to achieve accelerated growth. On behalf of the Board of Directors, I would like to thank Jim for leading our turnaround and the transformation of the Company into a leading hospitality software solutions provider with a growing cloud-based solution portfolio driving increased subscription-based revenues.”
Mr. Dennedy remarked, "I am proud of the team's accomplishments in returning the Company to growth through the successful launch of our rGuest platform and the ongoing adoption of our iconic solutions. I am confident that Agilysys has the right products and strategy in place that will allow us to further solidify our leadership role in the industry. I look forward to working with the Board and the next CEO to help deliver a seamless transition."
Separately, the Company announced that Chief Financial Officer, Janine Seebeck, has notified the Company that she is resigning from her position effective November 18, 2016 as she has accepted a CFO position at a company that does not compete with Agilysys. Ms. Seebeck’s resignation is not the result of any disagreement with the Board, management or the Company’s independent auditors with respect to the Company's financial or accounting practices. Tony Pritchett, the Company’s Senior Director of Operations, will serve as Interim CFO until the appointment of a permanent successor. Mr. Pritchett is a certified public accountant who joined Agilysys in 2012 as Controller of the Retail Solutions Group and has subsequently served as the Company’s Controller as well as in his current role as Senior Director of Operations.
Mr. Kaufman added, "Our accounting and finance department is well-staffed, experienced and capable, and we are confident that Tony will capably lead our team and facilitate a smooth transition.”
Agilysys today reaffirmed guidance for fiscal 2017 annual revenue to be in the range of $132 - $136 million. The Company will release its fiscal 2017 second quarter results after the market close on Wednesday, November 9, 2016 and host a conference call and webcast at 4:30 p.m. ET that day. Details of the conference call and webcast will be provided at a later time.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stonemor Partners (STON) Announces Resignation of CFO Sean McGrath
- Chemical Financial (CHFC) Names Jeffrey Tate to Board of Directors
- Eyegate Pharma (EYEG) Granted Canadian Patent for Proprietary Iontophoretic Formulation and Use
Create E-mail Alert Related CategoriesCorporate News, Management Changes, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!